Receptors small molecules

Herpin TF, Yu G, Carlson KE, et al. Discovery of tyrosine-based potent and selective melanocortin-1 receptor small-molecule agonists with anti-inflammatory properties, / Med Chem 2003 46 1123-26. 

Therefore, these drug molecules must cross the multiple layers of cellular membranes between the site of administration (the blood circulation in the case of intravenous injection) and their intracellular receptors. Small molecules (MW < 400 Da) that are soluble in both water and octanol readily diffuse through the biomembranes. Many hydrophilic small-molecule drugs such as [3-lactam antibiotics12 and classical antifolates13 require specific transporter proteins on the plasma membrane to enter the cytoplasm of the host cells. 

Figure 14.2 An autoexpand network generated around FXR illustrating the links to transporters and enzymes regulated by this nuclear receptor. Small molecules are shown as purple hexagons. The network was built using MetaCore version 4.

The stilbene derivative tamoxifen was the first synthetic nuclear receptor small-molecule modulator that demonstrated differential tissue effects. However, it has not found wide application as treatment for menopausal symptoms due to its stimulatory effects on the utems which cause a potential risk for endometrial cancer [53]. Despite this drawback tamoxifen is still used as a treatment for ER-positive breast cancer. 

Discovery targets receptors, small molecule drugs, large molecule drugs... 

Swinney, D. C., Beavis, P., Chuang, K. T., Zheng, Y., Lee, I., Gee, P., et al. (2014). A study oF the molecular mechanism of binding kinetics and long residence times of human CCR5 receptor small molecule allosteric Ugands. British Journal of Pharmacology, 171 U), 3364-3375. http //dx.doi.org/10.llll/bph.12683. 

Dmg receptors are chemical entities which are typically, but not exclusively, small molecules that interact with cellular components, frequently at the plasma membrane level (1,2). There are many types of receptors heat, light, immune, hormone, ion channel, toxin, and vims are but a few that can excite a cell. The receptor concept can be appHed generally to signal recognition processes where a chemical or physical signal is recognized. This recognition is translated into response (Fig. 3) and the process can be seen as a flow of information. 

Biochemically, most quaternary ammonium compounds function as receptor-specific mediators. Because of their hydrophilic nature, small molecule quaternaries caimot penetrate the alkyl region of bdayer membranes and must activate receptors located at the cell surface. Quaternary ammonium compounds also function biochemically as messengers, which are generated at the inner surface of a plasma membrane or in a cytoplasm in response to a signal. They may also be transferred through the membrane by an active transport system. 

These small-molecule thiols serve to transfer NO from erythrocytes to endothelial receptors, where it acts to relax vascular tension. NO itself is a reactive free-radical compound whose biological half-life is very short (1-5 sec). S-nitrosoglutathione has a half-life of several hours. 

While some biological targets such as DNA are not protein in nature, most receptors are. It is useful to consider the properties of receptor proteins to provide a context for the interaction of small molecule drugs with them. An important property of receptors is that they have a 3D structure. Proteins usually are comprised of one or... 

Precisely defined collections of different chemical compounds are denominated as chemical libraries that can be efficiently prepared by methods of combinatorial chemistry. Each chemical compound owes specific structural, steiic, and electronic properties that determine all possible interactions of the small molecule with a given protein or receptor. The molecule s properties are based on the steiic arrangement of functional groups, including the conformations that can be attained by a specific structure. 

Main differences between monoclonal antibodies and small-molecule receptor tyrosine kinases are described in Table 2. 

---